Cyclerion Therapeutics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.1 | $2.0 | $0.0 | $0.3 | $3.9 |
| Operating income | -$5.0 | -$3.6 | -$13.0 | -$18.5 | -$55.2 |
| Net income | -$3.5 | -$3.1 | -$5.3 | -$44.1 | -$51.6 |
| Cash Flow Statement | |||||
| Free cash flow | — | — | — | -$40.6 | -$36.5 |
Shares outstanding 4.7M · Free float 70.2%
Annual filing data through FY ended December 31, 2025; float as of October 4, 2026.